UNSPSC 51182014: Dutasteride

This classification denotes a 5 alpha-reductase inhibitor and anti-androgen with the molecular formula C27H30F6N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O0J6XJN02I, chemically known as alpha,alpha,alpha,alpha,alpha,alpha-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2,5-xylidide but generally known as dutasteride, which bears US NIH Compound Identifier 152945. European Medicines Agency schedules Dutasteride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06430MIG.

UNSPSC 51182014 Dutasteride is a Commodity code for a specific pharmaceutical product—a medication used to treat benign prostatic hyperplasia. However, the recent state and local contract opportunities tagged under this code show no purchasing activity for dutasteride itself. Instead, the tagged opportunities span athletic training services, general medical aid supplies, and pharmacy benefit program infrastructure—none of which involve dutasteride procurement. The mismatch suggests that either the code has been misapplied to these opportunities in the source system, or the code sees minimal relevant activity in current state and local markets.

No state and local governments have posted solicitations for dutasteride or related pharmaceutical products in the recent opportunities block. The code appears inactive for its nominal scope of work among the jurisdictions represented in this dataset.